Medical Yoga for Patients With Stress-related Symptoms

Stress-related Illness/Anxiety Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02907138
• Other study ID #: VGFOUGSB-602221
• Status: Completed
• Phase: N/A
• Start date: September 2016
• Est. completion date: March 4, 2019

Study information

• Verified date: September 2020
• Source: Vastra Gotaland Region
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to compare the effect of Medical Yoga as a group treatment, to conventional treatment provided by a physical therapist, for people with perceived stress-related symptoms.

Forty people are to be randomized to either:

1. Intervention Group - Medical Yoga, group treatment for eight weeks, 60 minutes per week, with the guidance of a physical therapist.

or

2. Control - treatment as usual (TAU) in physical therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: March 4, 2019
• Est. primary completion date: February 15, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Perceived stress and anxiety, which could be expressed as for example as tension in the neck and shoulders, insomnia, anxiety and headaches.

Exclusion Criteria:

• Do not understand Swedish (as group instructions need to be understood),

• Pregnancy,

• Psychotic symptoms,

• Ongoing or physical therapy treatment the last three months,

• Previously participated in Medical Yoga group.

Related Conditions & MeSH terms

• Stress-related Illness/Anxiety

Intervention

Other:
• Medical Yoga

• Treatment as Usual (physical therapy)

Locations

Country	Name	City	State
Sweden	Narhalsan Gibraltar rehabmottagning	Gothenburg

Sponsors (1)

Lead Sponsor	Collaborator
Maria Larsson

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Perceived Stress Scale (PSS)	Outcome will be measured as change between baseline and follow-ups and between follow-ups. Total score will also be analysed between groups at follow-up(s).	baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Secondary	Hospital Anxiety and Depression Scale (HADS)		baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Secondary	Health-related quality of Life; EQ5D		baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Secondary	Thorax excursion: Measured in centimeters with tape measure, chest size at the level of processus xiphoideus, the difference between the maximum inhalation and exhalation is registered		baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Secondary	Health-related quality of Life; EQ-VAS		baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session